AI Transforming Drug Discovery: Next Biotech Boom Ahead
Artificial intelligence is turbocharging drug discovery, cutting years from development timelines and sparking a surg...
At retirement, target date funds typically rebalance toward conservative assets, adjusting to support withdrawals while aiming to preserve principal.
20,347 articlesArtificial intelligence is turbocharging drug discovery, cutting years from development timelines and sparking a surg...
Forward Industries jumped after confirming it expanded its SOL holdings by more than 500,000 coins. Here’s what this ...
McDonald’s raised its quarterly dividend again as franchisees contend with higher costs and softer consumer demand. T...
The June jobs report shows tepid hiring even as unemployment falls, highlighting mixed signals for households and mar...
Ripple's XRP is edging higher as derivatives data shows falling open interest. Traders wonder whether this is short-c...
As policymakers migrate from restraint to regulation, Washington signals a bipartisan push for federal AI licensing, ...
The AI wave is accelerating, and savvy investors are looking for blue-chip names with durable AI catalysts. This guid...
Solana’s on-chain data show real-world asset transfers surging to $8.68 billion in the last 30 days, with asset value...
Iran tensions could ripple through travel, housing and markets beyond fuel costs. Analysts warn that higher prices ar...
The EU is gearing up for a major MiCA update in 2027 to cover non‑EU stablecoin issuers and tokenized payments. This ...
Swift moves from sandbox to live trial, coordinating tokenized deposits across 17 banks to speed cross-border settlem...
If you’ve wondered why amazon much cheaper than Walmart and Costco in the stock market, you’re not alone. This articl...